Repare Therapeutics Inc.
NASDAQ:RPTX
3.58 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1.073 | 52.404 | 13.047 | 2.159 | 30.249 | 5.678 | 18.198 | 112.545 | 0.679 | 0.408 | 6.877 | 0.278 | 0.279 | 0.166 | 0.135 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.488 | 0.501 | 0.506 | 1.049 | 1.051 | 0.982 | 1.018 | 31.242 | 1.07 | 26.458 | 0.993 | 25.361 | 20.205 | 16.509 | 11.101 | 10.091 | 8.951 | 8.632 | 20.275 | 0 | 0 | 0 |
| Gross Profit
| 0.585 | 51.903 | 12.541 | 1.11 | 29.198 | 4.696 | 17.18 | 81.303 | -0.391 | -26.05 | 5.884 | -25.083 | -19.926 | -16.343 | -10.966 | -10.091 | -8.951 | -8.632 | -20.275 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.545 | 0.99 | 0.961 | 0.514 | 0.965 | 0.827 | 0.944 | 0.722 | -0.576 | -63.848 | 0.856 | -90.227 | -71.419 | -98.452 | -81.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 29.327 | 32.469 | 34.46 | 32.709 | 33.788 | 31.83 | 29.891 | 31.242 | 31.475 | 26.458 | 27.972 | 25.361 | 20.205 | 16.509 | 12.417 | 10.091 | 8.951 | 8.632 | 6.821 | 5.618 | 4.853 | 3.703 |
| General & Administrative Expenses
| 8.317 | 8.618 | 8.648 | 7.868 | 8.719 | 8.529 | 7.939 | 7.904 | 7.938 | 8.779 | 7.639 | 6.596 | 6.741 | 5.237 | 4.792 | 3.996 | 3.372 | 2.183 | 2.024 | 1.25 | 1.032 | 1.076 |
| Selling & Marketing Expenses
| 0 | 0 | -0.116 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 8.317 | 8.618 | 8.532 | 7.868 | 8.719 | 8.529 | 7.939 | 7.904 | 7.938 | 8.779 | 7.639 | 6.596 | 6.741 | 5.237 | 4.792 | 3.996 | 3.372 | 2.183 | 2.024 | 1.25 | 1.032 | 1.076 |
| Other Expenses
| -0.029 | -0.024 | -0.046 | -0.032 | -0.026 | -0.015 | 0.013 | -0.037 | -0.011 | -0.008 | -0.02 | -0.007 | -0.007 | -0.007 | -0.006 | -0.004 | -0.004 | -0.002 | -0.014 | -0.639 | -0.681 | -0.022 |
| Operating Expenses
| 37.644 | 41.087 | 42.992 | 40.577 | 42.507 | 40.359 | 37.83 | 39.146 | 39.413 | 35.237 | 35.611 | 31.957 | 26.946 | 21.746 | 17.209 | 14.087 | 12.323 | 10.815 | 8.845 | 6.868 | 5.885 | 4.779 |
| Operating Income
| -37.059 | 10.816 | -30.451 | -38.418 | -12.258 | -34.681 | -19.632 | 73.399 | -38.734 | -34.829 | -28.734 | -31.679 | -26.667 | -21.58 | -17.074 | -14.087 | -12.323 | -10.815 | -8.845 | -6.868 | -5.885 | -4.779 |
| Operating Income Ratio
| -34.538 | 0.206 | -2.334 | -17.794 | -0.405 | -6.108 | -1.079 | 0.652 | -57.046 | -85.365 | -4.178 | -113.953 | -95.581 | -130 | -126.474 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 2.871 | 2.975 | 3.027 | -0.072 | -0.067 | 3.356 | 3.002 | 0.089 | 0.674 | 0.104 | -0.072 | 0.026 | -0.101 | -0.038 | 0.175 | 0.286 | 0.591 | -1.733 | 0.551 | -0.791 | -0.454 | 0.05 |
| Income Before Tax
| -34.188 | 13.791 | -27.424 | -35.178 | -8.836 | -31.325 | -16.63 | 75.515 | -38.06 | -34.725 | -28.702 | -31.6 | -26.73 | -21.554 | -16.815 | -13.645 | -11.732 | -12.548 | -8.294 | -7.659 | -6.339 | -4.729 |
| Income Before Tax Ratio
| -31.862 | 0.263 | -2.102 | -16.294 | -0.292 | -5.517 | -0.914 | 0.671 | -56.053 | -85.11 | -4.174 | -113.669 | -95.806 | -129.843 | -124.556 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.586 | 0.629 | 0.606 | -16.299 | 3.11 | 3.616 | 15.028 | 0.054 | 0.033 | 0.032 | -0.412 | -0.708 | -0.421 | -0.137 | -1.554 | 0.106 | 0.07 | 0.053 | 0.037 | 0.029 | 0.02 | 0.109 |
| Net Income
| -34.774 | 13.162 | -28.03 | -18.879 | -11.946 | -34.941 | -31.658 | 75.461 | -38.093 | -34.757 | -28.29 | -30.892 | -26.309 | -21.417 | -15.261 | -13.751 | -11.802 | -12.601 | -8.331 | -7.688 | -6.359 | -4.838 |
| Net Income Ratio
| -32.408 | 0.251 | -2.148 | -8.744 | -0.395 | -6.154 | -1.74 | 0.67 | -56.102 | -85.189 | -4.114 | -111.122 | -94.297 | -129.018 | -113.044 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.82 | 0.31 | -0.67 | -0.45 | -0.28 | -0.83 | -0.75 | 1.8 | -0.91 | -0.83 | -0.71 | -0.83 | -0.71 | -0.58 | -0.41 | -0.37 | -2.45 | -0.4 | -0.36 | -0.33 | -0.27 | -0.21 |
| EPS Diluted
| -0.82 | 0.3 | -0.67 | -0.45 | -0.28 | -0.83 | -0.75 | 1.71 | -0.91 | -0.83 | -0.7 | -0.83 | -0.71 | -0.58 | -0.41 | -0.37 | -2.45 | -0.4 | -0.36 | -0.33 | -0.27 | -0.21 |
| EBITDA
| -36.571 | 11.317 | -29.945 | -38.378 | -11.711 | -34.625 | -19.235 | 73.757 | -38.352 | -34.296 | -28.682 | -31.343 | -26.161 | -21.227 | -17.255 | -14.17 | -12.711 | -8.888 | -9.221 | -6.562 | -5.972 | -4.729 |
| EBITDA Ratio
| -34.083 | 0.216 | -2.295 | -17.776 | -0.387 | -6.098 | -1.057 | 0.655 | -56.483 | -84.059 | -4.171 | -112.745 | -93.767 | -127.873 | -127.815 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |